GPH-102

N/A

Report date: 2025/08/21 17:31:00

Base Information

Drug NameGPH-102
Drug Alias NameGPH102GPH-102
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionGene transferenceCell replacementsHemoglobin beta chain stimulants
TargetsHemoglobin beta chain
Therapy Area/Indicationsbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLenz Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLenz Therapeutics Inc
Inactive CompaniesN/A
Active Indicationsbeta-Thalassemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A